Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 175 results for "sarabjit kour nangra"

Health Canada asks importers to quarantine drugs from Dr. Reddy's facilities
Livemint.com

DR REDDY LABORATORIES : Health Canada enforces import ban on D...

In another setback, Indian drug manufacturers have now come under the scanner of the Canadian health regulator, Health Canada . A number of pharma companies are already under the lens of the US Food and Drug Administration (FDA) over ... 4 Traders, 2 days ago
Canada bans imports from Dr Reddy's, IPCA units Hindu Business Line, 3 days ago

1 images for "sarabjit kour nangra"

Times of India, 1 month ago
MedIndia

IPCA, Dr Reddy's Health Products Come Under Canada Govt ...

Canadian importers have been asked to quarantine health products made at IPCA Laboratories' Pithampur facility in Madhya Pradesh and Dr Reddy's Laboratories' Srikakulam plant in Andhra Pradesh due to data integrity concerns. The order was ...
 MedIndia2 days ago

CIPLA : arm bags Rs1,100 cr anti-Aids drug contract from South Africa

Mumbai : Durgmaker Cipla on Tuesday announced that its South African subsidiary has won order worth 2 billion rand (nearly Rs 1,100 crore ) for its anti-Aids drugs from the South African government. The company in its filing on BSE said its ...
 4 Traders3 days ago Cipla bags Rs 1,100 crore anti-Aids drug contract from South Africa  DNA India4 days ago

Canadian importers to quarantine products from DRL, IPCA facilities

Comment · print · T T T+· T- TOPICS Action applies to active pharmaceutical ingredients from DRL as well as to finished drug products from a different IPCA Laboratories facility, Health Canada said. Canadian importers have decided to ...
 The Hindu3 days ago
Livemint.com

Angel Broking recommends Buy on HCL Technologies

HCL Technologies, which is expected to announce its second quarter (October-December' 14) earnings in the last week of January 2015, yesterday released its pre-earning forecast. The Company, through this pre-earnings brief, highlighted how the ...
 MyIris5 days ago Angel Broking maintains 'Neutral' on Cipla  MyIris2 weeks ago Ranbaxy's Nexium pay-for-delay case to go on trial  Financial Chronicle1 month ago Angel Broking remains neutral on Ranbaxy  MyIris1 month ago

Infosys targets return to glory days as market perception turns positive

With its renew and new strategy, Infosys is expected to catch up with its peers, get back to industry-leading growth and margins by the end of the 2016 financial year, but would continue to struggle in the near term. The Bangalore-based company ...
 Hindu Business Line5 days ago

DRL's unit receives US FDA observations on possible lapses

The US Food and Drug Administration (US FDA) has found what it calls nine inspectional observations at Unit VI of Dr Reddy's Laboratories The US Food and Drug Administration (US FDA) has found what it calls nine inspectional observations at Unit ...
 Financial Express6 days ago Dr Reddy's unit receives USFDA observations on possible lapses  Financial Express1 month ago We maintain neutral stance on Dr Reddy`s: Angel Broking  MyIris1 month ago Dr Reddy's unit receives US FDA observations on possible lapses  Financial Express1 month ago

Going gets tough

Sector review: Information Technology Calendar 2014 brought hopes of better prospects for the IT industry on improving economic situation in the target markets. Most IT majors were confident that 2014-15 would be better than the previous year. However, the ...
 The Financial Chronicle6 days ago

Rouble fallout: Dr Reddy's, Ranbaxy's profit in trouble

Depreciation of the Russian currency poses a risk to the profitability of Indian pharma companies such as Dr Reddy's, Glenmark and Ranbaxy. Russia, a key market for these companies, contributes 5% of overall Indian pharma exports. RussiaCIS ...
 Economic Times1 week ago Rouble fallout: Indian pharma companies need a cure to beat emerging crisis  Times of India1 week ago Brokerages bullish on Dr Reddy's despite rouble concerns  Economic Times1 week ago

Ranbaxy Laboratories : Labs to take its novel drug Synriam to Africa

Mumbai : Drug manufacturer Ranbaxy Laboratories said that it has received regulatory approval to launch its new chemical entity (NCE) Synriam in seven African countries namely Nigeria , Uganda , Senegal , Cameroon , Guinea , Kenya and Ivory Coast .
 4 Traders1 week ago Ranbaxy gets nod to sell drug treating malaria in 7 African nations  DNA India1 week ago US court overturns Ranbaxy bid to block launch of rival generic drugs  MyIris1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less